Evidence map›Paper›PMID 41398284›Full record

ArticleJournal of nanobiotechnology2025

H

Daifeng Li, Lurui Yang, Liuliang He, Bowen Liu, Yuhui Yuan, Zhichao Wang, Jinjin Shi, Yi Zhang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of nanobiotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Daifeng LiDepartment of Orthopedics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China. lidaifeng@zzu.edu.cn.
Lurui YangDepartment of Orthopedics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
Liuliang HeDepartment of Orthopedics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
Bowen LiuDepartment of Orthopedics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
Yuhui YuanDepartment of Orthopedics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
Zhichao WangDepartment of Orthopedics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
Jinjin ShiSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, 450001, China. shijinyxy@zzu.edu.cn.
Yi ZhangDepartment of Orthopedics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China. zhangyi@zzu.edu.cn.

Funding

Clinical Medical Scientist of Henan Province S20240059National Natural Science Foundation of China 82102588Natural Science Foundation of Henan Province 232300421050, 242301420068Young Elite Scientists Sponsorship Program by CAST 2023QNRC001
6 · The paper itself

Abstract

In contemporary antibacterial treatment, the inability to effectively penetrate biofilm structures, coupled with the rising prevalence of antimicrobial resistance, significantly compromise the clinical efficacy of antibiotic-based therapies. Herein, we propose a hydrogen peroxide (H

Indexed as

Anti-Bacterial AgentsBiofilmsHydrogen PeroxideMetal NanoparticlesVancomycinAnimalsDrug Resistance, BacterialDrug SynergismHumansMiceMicrobial Sensitivity TestsPoloxamerRAW 264.7 CellsSilverTanninsAnti-Bacterial AgentsHydrogen PeroxidePoloxamerSilverTanninsVancomycinBiofilm infectionsDrug-resistant bacteriaJanus nanomotorsSelf-assemblySilver nanoparticles

Identifiers

PMID41398284
PMCPMC12822349

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.